Subscribe
type here...
Subscribe

Tag: BIOCAD

The Ministry of Health of Russia authorizes a Russian anti-melanoma originator

Manufacturing Techno -
The Ministry of Health of the Russian Federation has authorized a Russian originator drug for the treatment of unresectable or metastatic melanoma. The product was developed by BIOCAD, a biotechnology company; it is a fixed dose combination of two monoclonal antibodies, nurulimab and prolgolimab.

The Russian Ministry of Health has authorized the first Russian originator for the treatment of multiple sclerosis

Manufacturing Techno -
The Ministry of Health of the Russian Federation has authorized the first Russian originator for the treatment of multiple sclerosis...

A Clinical Trial of a Russian Originator for the Treatment of Cervical Cancer Started in China

Drug Development Techno -
A joint venture between the biotechnology company BIOCAD and Shanghai Pharmaceuticals Holding has announced the enrollment of the first...

The clinical trial for an original Russian lung cancer drug has started in China

Drug Development Techno -
The BIOCAD and Shanghai Pharmaceuticals Holding joint venture has announced the enrollment of the first Chinese patient in the...

А phase III study proven the efficacy of the bevacizumab biosimilar in patients with late stages of NSCLC

Drug Development Techno -
New results for Phase III study of BCD-021, a bevacizumab biosimilar, were presented as a poster at the European...

Russian Health Ministry permits Biocad to conduct clinical trials of new COVID vaccine

Drug Development Techno -
The state registry notes that the trials will last until late 2026 and will involve 360 patients. The vaccine will be administered via an intramuscular injection.

Russia to produce 90 mln anti-COVID-19 vaccine sets by October

Manufacturing Techno -
We plan to hit the production figure of 30 million sets in July and this figure will be approximately the same for August and September, Manturov said.

BIOCAD has registered an original drug for the treatment of rheumatoid arthritis

Manufacturing Techno -
The Ministry of Health of the Russian Federation has approved the original drug Levilimab (Russian trade name Ilsira) for...

BIOCAD has presented the results of efficacy evaluation of the Russian immuno-oncology product prolgolimab for the treatment of melanoma

Manufacturing Techno -
In the evening of June 21, 2021, leading Russian and international cancer experts presented the results of a three-year...

BIOCAD has received approval from the Chinese authorities to conduct clinical trials of prololimab for the treatment of cervical cancer and NSCLC

Manufacturing Techno -
SPH BIOCAD, a joint venture with Shanghai Pharmaceuticals Holding, which is registered in Hong Kong and has a representative...

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

“Golden” Potency: 2.4 Billion Rubles Wasted on “Russian Viagra” Project

0
A scandal in the state pharmaceutical sector: The Accounts...

Eurasian Pharma Register Cannot Be Used to Disqualify Tender Bids

0
A significant ruling for Russian pharmaceutical distributors: The Arbitration...

Good AI Practice: EMA and FDA Establish 10 Global Principles

0
Global regulators are setting a unified standard for the...

Cosmic Viruses Prove More Effective Than Earth Medicines

0
A team of microbiologists from the University of Wisconsin-Madison has unveiled results from a unique study conducted aboard the International Space Station (ISS).

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026